Recent population-based studies have shown that elevated levels of granulocyte-macrophage colony-stimulating factor (GM-CSF), predominantly secreted by B lymphocytes, are associated with increased osteoporosis risk, highlighting the role of immune dysregulation in bone loss [11,12]. Here, CSF2 is linked to osteoporosis.